×
About 34,003 results

ALLMedicine™ Neutropenia Center

Research & Reviews  8,083 results

Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation.
https://doi.org/10.1080/14787210.2023.2151440
Expert Review of Anti-infective Therapy; Akhmedov M, Klyasova G et. al.

Nov 24th, 2022 - Although colonization is an established risk factor for bloodstream infection (BSI) due to identical strain, prior infection with resistant bacteria should also be considered during the management of febrile neutropenia. This study aimed to analyz...

Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated ...
https://doi.org/10.1200/JCO.21.02734
Journal of Clinical Oncology : Official Journal of the Am... Sonneveld P, Chanan-Khan A et. al.

Nov 23rd, 2022 - At the primary analysis of CASTOR (median follow-up, 7.4 months), daratumumab plus bortezomib and dexamethasone (D-Vd) significantly prolonged progression-free survival versus bortezomib and dexamethasone (Vd) alone in relapsed or refractory multi...

Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic co...
https://doi.org/10.1182/bloodadvances.2022008226
Blood Advances; Clerici D, Galli L et. al.

Nov 22nd, 2022 - Fluoroquinolone prophylaxis (FQ-P) usefulness in neutropenic patients is controversial. In recent decades, Italian epidemiological data has shown worrisome rates of FQ resistance. A single-center cohort study on 136 autologous stem cell transplant...

Treatment-related adverse events of antibody-drug conjugates in clinical trials: A syst...
https://doi.org/10.1002/cncr.34507
Cancer Zhu Y, Liu K et. al.

Nov 22nd, 2022 - Antibody-drug conjugates (ADCs) have complex molecular structures and have been tested in numerous clinical trials. Therefore, understanding the mechanisms of their toxicity when applied in medical practice is of high importance. In a systematic r...

Reactive granulopoiesis depends on T-cell production of IL-17A and neutropenia-associat...
https://doi.org/10.1073/pnas.2211230119
Proceedings of the National Academy of Sciences of the Un... Chen X, Hashimoto D et. al.

Nov 22nd, 2022 - Granulopoiesis in the bone marrow adjusts cellular output as demand for neutrophils changes. Reactive granulopoiesis is induced by profound neutropenia, but its mechanism remains to be clarified. We herein explored its mechanisms using mouse model...

see more →

Guidelines  16 results

Emerging challenges in the evaluation of fever in cancer patients at risk of febrile ne...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682766
Supportive Care in Cancer : Official Journal of the Multi... Cooksley T, Font C et. al.

Nov 25th, 2020 - Patients with cancer are at higher risk of more severe COVID-19 infection and have more associated complications. The position paper describes the management of cancer patients, especially those receiving anticancer treatment, during the COVID-19 ...

Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 19th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

ACR Appropriateness Criteria® Acute Nonlocalized Abdominal Pain.
https://doi.org/10.1016/j.jacr.2018.09.010
Journal of the American College of Radiology : JACR; , Scheirey CD et. al.

Nov 6th, 2018 - The range of pathology in adults that can produce abdominal pain is broad and necessitates an imaging approach to evaluate many different organ systems. Although localizing pain prompts directed imaging/management, clinical presentations may vary ...

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASC...
https://doi.org/10.1200/JCO.18.00374
Journal of Clinical Oncology : Official Journal of the Am... Taplitz RA, Kennedy EB et. al.

Sep 5th, 2018 - To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA) guideline on antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment. ASCO and IDSA convened an update Expert Panel...

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: Americ...
https://doi.org/10.1200/JCO.2017.77.6211
Journal of Clinical Oncology : Official Journal of the Am... Taplitz RA, Kennedy EB et. al.

Feb 21st, 2018 - Purpose To provide an updated joint ASCO/Infectious Diseases Society of American (IDSA) guideline on outpatient management of fever and neutropenia in patients with cancer. Methods ASCO and IDSA convened an Update Expert Panel and conducted a syst...

see more →

Drugs  402 results see all →

Clinicaltrials.gov  794 results

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
https://clinicaltrials.gov/ct2/show/NCT03691493

Oct 14th, 2022 - PRIMARY OBJECTIVE: I. To evaluate the response rate three months post-conventionally fractionated radiotherapy, relative to baseline, for bone metastases in breast cancer patients receiving concurrent palbociclib and hormone therapy treatment. SEC...

Improving White Blood Cell Collection From Healthy Donors
https://clinicaltrials.gov/ct2/show/NCT01553214

Oct 14th, 2022 - Bacterial and fungal infections in neutropenic patients or in patients with inherited disorders of neutrophil function continue to cause substantial morbidity and mortality. In particular, fungal infections are an increasingly important cause of d...

Cancer in Inherited Bone Marrow Failure Syndromes
https://clinicaltrials.gov/ct2/show/NCT00027274

Oct 14th, 2022 - Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic ca...

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
https://clinicaltrials.gov/ct2/show/NCT03978624

Oct 13th, 2022 - The study will enroll 20 subjects with a confirmed diagnosis of MIBC (cT2-T4aN0M0) who are planned for definitive therapy with either radical cystectomy without cisplatin-based neoadjuvant chemotherapy or trimodality therapy. Subjects who are plan...

Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy
https://clinicaltrials.gov/ct2/show/NCT05576220

Oct 12th, 2022 - The purpose of the study is to evaluate the remote patient temperature monitoring service of the Idion Shield system in patients undergoing outpatient stem cell transplantation or CAR-T therapy who are at risk for developing infections and/or cyto...

see more →

News  4,299 results

FDA Approves Additional Dosing Schedule for Rylaze in ALL and LBL
https://www.onclive.com/view/fda-approves-additional-intramuscular-dosing-schedule-for-rylaze-in-all-and-lbl

Nov 18th, 2022 - The FDA has approved a supplemental biologics license application to add a Monday/Wednesday/Friday (MWF) intramuscular dosing schedule for asparaginase erwinia chrysanthemi (recombinant)-rywn (Rylaze).1 In June 2021, Rylaze was approved for use a...

Camsirubicin Elicits Early Clinical Activity in Advanced Soft Tissue Sarcoma
https://www.onclive.com/view/camsirubicin-elicits-early-clinical-activity-in-advanced-soft-tissue-sarcoma

Nov 18th, 2022 - The doxorubicin analogue camsirubicin in combination with pegfilgrastim (Neulasta) produced encouraging clinical activity and safety in patients with advanced soft tissue sarcoma, according to data from a phase 1b trial (NCT05043649).1 Findings s...

Ubamatamab Monotherapy Elicits Responses in Heavily Pretreated Ovarian Cancer
https://www.onclive.com/view/ubamatamab-monotherapy-elicits-responses-in-heavily-pretreated-ovarian-cancer

Nov 17th, 2022 - Ubamatamab (REGN4018) monotherapy produced early clinical activity and an acceptable risk/benefit profile in heavily pretreated patients with ovarian cancer, according to data from a phase 1 trial (NCT03564340) presented at the 2022 ESMO Congress....

Treatments Branch Out in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma
https://www.onclive.com/view/treatments-branch-out-in-newly-diagnosed-and-relapsed-refractory-multiple-myeloma

Nov 17th, 2022 - Therapeutic strategies such as defining the optimal timing of autologous stem cell transplant (ASCT), implementing CAR T-cell agents, and introducing BCMA-directed bispecific antibodies are building on current standards of care (SOCs) in multiple ...

FDA Requests Restriction of Second-line Maintenance Niraparib Indication in Ovarian Cancer
https://www.onclive.com/view/fda-requests-restriction-of-second-line-maintenance-niraparib-indication-in-ovarian-cancer

Nov 17th, 2022 - At the request of the FDA, GlaxoSmithKline (GSK) plc will restrict the second-line maintenance indication for niraparib (Zejula) to only the population of patients with recurrent ovarian cancer whose tumors harbor deleterious or suspected deleteri...

see more →

Patient Education  7 results see all →